New Stem Cell Model to Aid Sun Sensitivity Research

Scientists have successfully engineered a new line of human stem cells to help investigate Xeroderma Pigmentosum group A (XPA), a severe genetic condition. Individuals with XPA suffer from defects in the nucleotide excision repair (NER) pathway, a biological system essential for fixing DNA damage caused by ultraviolet (UV) light. When this pathway fails, genetic errors accumulate, leading to genomic instability and a significantly higher risk of developing skin cancers.

In this study, the research team utilised CRISPR/Cas9 gene editing to introduce a specific mutation into the XPA gene within human induced pluripotent stem cells (iPSCs). These iPSCs are powerful cells capable of transforming into any tissue type in the body. Crucially, the edited cells retained their normal structure and ability to differentiate, acting just like healthy stem cells aside from the specific genetic flaw. This provides a reliable, identical model for scientists to dissect the molecular consequences of XPA deficiency and explore new therapeutic strategies.